Literature DB >> 6179386

Investigation of the role of kidney kallikrein on bumetanide induced diuresis in rats.

U B Olsen.   

Abstract

Administered to anaesthetized, laparatomized rats bumetanide (10 mg/kg intravenously) evoked a rapid and large diuretic response. This was associated with three to five fold enhancements of urine kallikrein (kininogenase) excretion. In addition bumetanide slightly decreased (approximately 10 mmHg) the blood pressure and temporarily increased renal blood flow (less than 10%). The capacity of bumetanide to increase urine kallikrein excretion was inhibited either by pretreatment with chlorazanil (3 mg/kg intravenously) or by the infusion of aprotinin (5000 KIE/kg/min). Kallikrein inhibition did not significantly modify bumetanide induced diuresis, natriuresis, kaliuresis, lowering of blood pressure or renal vasodilating effect.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6179386     DOI: 10.1111/j.1600-0773.1981.tb00914.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  2 in total

1.  Bumetanide inhibits rapid kindling in neonatal rats.

Authors:  Andréy Mazarati; Don Shin; Raman Sankar
Journal:  Epilepsia       Date:  2009-02-26       Impact factor: 5.864

Review 2.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.